Concepedia

Erkut Bahceci

EB

44

Publications

5.3K

Citations

28

H-Index

1993

Active since

Affiliations

Astellas Pharma (United States)(Current)

University of Pennsylvania

Johns Hopkins University

The University of Texas MD Anderson Cancer Center

Sidney Kimmel Comprehensive Cancer Center

Erkut Bahceci is an author at Astellas Pharma (United States) specializing in medicine, oncology, and immunology.

Top concepts

Publications per year

1993–2022

44

Publications

44

Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML

Alexander E. Perl, Giovanni Martinelli, Jörge E. Cortes et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

Richard Childs, Allen Chernoff, Nathalie Contentin et al. · New England Journal of Medicine · 2000 · 1K citations · Full text

Engraftment Kinetics After Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation: Full Donor T-Cell Chimerism Precedes Alloimmune Responses

Richard Childs, Emmanuel Clave, Nathalie Contentin et al. · Blood · 1999 · 527 citations

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

Alexander E. Perl, Jessica K. Altman, Jörge E. Cortes et al. · The Lancet Oncology · 2017 · 484 citations · Full text

, , +6

Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease

Partow Kebriaei, Luis Isola, Erkut Bahceci et al. · Biology of Blood and Marrow Transplantation · 2009 · 431 citations · Full text

Rows per page

1–5 of 44